Primary tabs

Single Vial System SVS

Spyridon Tsakas of Eulysis UK Limited in the United Kingdom will test an innovative single vial system (SVS) technology that allows for easier transport, reconstitution, and storage of vaccines with lyophilized components. Data gathered on its packaging, transportability and in situ lyophilization potential will help optimize the technology for safe vaccine delivery to the developing world.

Grant ID
OPP1056753
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False